Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takako Asano

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Translational Oncology|March 9, 2019
Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein KinaseKazuki Okubo, Makoto Isono, Takako Asano, et al.
The Journal of Urology|October 24, 2012
Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cellsAkinori Sato, Takako Asano, Keiichi Ito, et al.
BMC Urology|September 2, 2014
Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cellsAkinori Sato, Takako Asano, Makoto Isono, et al.
Anticancer Research|June 1, 2018
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
The Journal of Urology|January 10, 2004
Modulation of tumor growth and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 in renal cell carcinomaJunichi Asakuma, Makoto Sumitomo, Takako Asano, et al.
Oncology Research|October 8, 2016
Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer CellsMakoto Isono, Akinori Sato, Kazuki Okubo, et al.
Cancer Research|March 22, 2003
Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxelJunichi Asakuma, Makoto Sumitomo, Takako Asano, et al.
Molecular and Clinical Oncology|October 4, 2014
Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growthAkinori Sato, Takako Asano, Makoto Isono, et al.
Translational Oncology|June 18, 2021
Simvastatin-romidepsin combination kills bladder cancer cells synergisticallyKazuki Okubo, Kosuke Miyai, Kimi Kato, et al.
Anticancer Research|October 3, 2018
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Translational Oncology|March 9, 2019
Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein KinaseKazuki Okubo, Makoto Isono, Takako Asano, et al.
The Journal of Urology|October 24, 2012
Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cellsAkinori Sato, Takako Asano, Keiichi Ito, et al.
BMC Urology|September 2, 2014
Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cellsAkinori Sato, Takako Asano, Makoto Isono, et al.
Anticancer Research|June 1, 2018
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
The Journal of Urology|January 10, 2004
Modulation of tumor growth and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 in renal cell carcinomaJunichi Asakuma, Makoto Sumitomo, Takako Asano, et al.
Oncology Research|October 8, 2016
Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer CellsMakoto Isono, Akinori Sato, Kazuki Okubo, et al.
Cancer Research|March 22, 2003
Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxelJunichi Asakuma, Makoto Sumitomo, Takako Asano, et al.
Molecular and Clinical Oncology|October 4, 2014
Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growthAkinori Sato, Takako Asano, Makoto Isono, et al.
Translational Oncology|June 18, 2021
Simvastatin-romidepsin combination kills bladder cancer cells synergisticallyKazuki Okubo, Kosuke Miyai, Kimi Kato, et al.
Anticancer Research|October 3, 2018
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
Pageof 8